181 – 190 of 320
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Trophic Factor Gene Therapy for Parkinson's Disease
- Contribution to journal › Scientific review
-
Mark
Optogenetic cell control in experimental models of neurological disorders
- Contribution to journal › Scientific review
-
Mark
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration
- Contribution to journal › Article
-
Mark
The behavioural and neuropathological impact of intranigral AAV-alpha-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats
- Contribution to journal › Article
-
Mark
mTOR Inhibition Alleviates L-DOPA-Induced Dyskinesia in Parkinsonian Rats
- Contribution to journal › Article
-
Mark
Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: Behavior, positron emission tomography, immunohistochemistry
- Contribution to journal › Article
-
Mark
Variability in Neuronal Expression of Dopamine Receptors and Transporters in the Substantia Nigra
- Contribution to journal › Article
-
Mark
AC-186, a Selective Nonsteroidal Estrogen Receptor beta Agonist, Shows Gender Specific Neuroprotection in a Parkinson's Disease Rat Model
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients
- Contribution to journal › Article
-
Mark
Mechanisms underlying cortical resonant states: implications for levodopa-induced dyskinesia
- Contribution to journal › Article
